Prime Medicine, Inc. (PRME)
NASDAQ: PRME · Real-Time Price · USD
3.240
-0.235 (-6.76%)
Feb 5, 2026, 4:00 PM EST - Market closed
Prime Medicine Market Cap
Prime Medicine has a market cap or net worth of $573.6 million as of February 6, 2026. Its market cap has increased by 54.48% in one year.
Market Cap
573.60M
Enterprise Value
478.45M
1-Year Change
54.48%
Ranking
Category
Stock Price
$3.24
Market Cap Chart
Since the IPO on October 20, 2022, Prime Medicine's market cap has decreased from $1.63B to $573.60M, a decrease of -64.75%. That is a compound annual growth rate of -27.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 4, 2026 | 615.21M | 0.14% |
| Dec 31, 2025 | 614.32M | 64.88% |
| Dec 31, 2024 | 372.58M | -54.41% |
| Dec 29, 2023 | 817.15M | -49.22% |
| Dec 30, 2022 | 1.61B | -1.12% |
| Oct 20, 2022 | 1.63B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| MiMedx Group | 736.07M |
| Gyre Therapeutics | 719.85M |
| Kura Oncology | 716.15M |
| SELLAS Life Sciences Group | 708.37M |
| Fulcrum Therapeutics | 692.03M |
| Altimmune | 685.02M |
| enGene Holdings | 667.84M |
| Rigel Pharmaceuticals | 657.08M |